STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more
STAT
SEPTEMBER 12, 2024
This calls for celebration with a cup of stimulation, and we are opening a new package of pecan pie for the occasion. billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate, STAT writes. Sound familiar? Have a great day, everyone.
Let's personalize your content